Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and quad pill

lamivudine has been researched along with quad pill in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Andany, N; Gold, WL1
Emerson, CR; Todd, S1
Bonazzetti, C; Conti, F; Formenti, T; Galli, M; Giacomelli, A; Morena, V; Oreni, L; Pagani, G; Pezzati, L; Ridolfo, AL; Rusconi, S1

Other Studies

3 other study(ies) available for lamivudine and quad pill

ArticleYear
Single-tablet antiretroviral treatment (once daily).
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Sep-20, Volume: 188, Issue:13

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Interactions; Drug Resistance, Viral; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Mental Disorders; Oxazines; Piperazines; Pyridones; Viral Load

2016
A severe hypersensitivity reaction to abacavir following re-challenge.
    International journal of STD & AIDS, 2017, Volume: 28, Issue:3

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; HLA-B Antigens; Humans; Lamivudine; Oxazines; Piperazines; Pyridones

2017
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study.
    BMC infectious diseases, 2021, Jun-22, Volume: 21, Issue:1

    Topics: Adult; Anti-HIV Agents; Body Weight; Cohort Studies; Dideoxynucleosides; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Female; Heart Disease Risk Factors; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Italy; Lamivudine; Lipid Metabolism; Lipids; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Tablets

2021